Frederick Pierce
Patrimonio netto: 143 209 $ in data 31/07/2026
Patrimonio netto: 143 209 $ in data 31/07/2026
Frederick E.
Pierce was the founder of Decoy Therapeutics, Inc. (Old), founded in 2020, holding the title of Chief Executive Officer & Director.
Mr. Pierce is the founder of Decoy Therapeutics, Inc., founded in 2025, holding the title of Chief Executive Officer & Director.
Mr. Pierce is also the founder of FEP Capital Advisors LLC..
Mr. Pierce is currently Director at Canadian Entrepreneurs In New England.
Former positions include Interim Chief Executive Officer at Glycogenesys, Inc. from 1998 to 2006; Chairman & Chief Executive Officer at Microbial Machines, Inc.; Chairman, President & Chief Executive Officer at Innovation1 Biotech, Inc. from 2022 to 2024; Chief Executive Officer & Director at Salarius Pharmaceuticals, Inc.; Chairman at Leadership Counsel for Justice & Accountability from 2017 to 2020; President-US & International Operations at SemBioSys Genetics, Inc.; Vice President-Investor Relations at Javelin Pharmaceuticals, Inc.; and Vice President-Investor & Media Relations at MetaStat, Inc. Education includes undergraduate studies at Hampshire College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
5,32% | 31/08/2026 | 34.844 ( 5,32% ) | 143 209 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Operates membership organization to support Canadian technology and life sciences entrepreneurs | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| INNOVATION1 BIOTECH INC. | Amministratore Delegato | 07/11/2024 |
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Provides research, legal representation and policy advocacy services | Presidente | 01/01/2020 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Presidente | 01/06/2006 |
| DECOY THERAPEUTICS INC. | Amministratore Delegato | - |
Decoy Therapeutics, Inc.
Decoy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical biopharmaceutical company | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Commercial Services |
SemBioSys Genetics, Inc.
SemBioSys Genetics, Inc. BiotechnologyHealth Technology Develops protein-based pharmaceuticals and non-pharmaceutical products | Health Technology |
Hampshire College
Hampshire College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
MetaStat, Inc.
MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
FEP Capital Advisors LLC | |
Innovation1 Biotech, Inc.
Innovation1 Biotech, Inc. Internet RetailRetail Trade Sells consumer cannabidiol products through online | Retail Trade |
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Operates membership organization to support Canadian technology and life sciences entrepreneurs | Commercial Services |
Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on developing treatment for cancer | Health Technology |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan diseases drugs | Health Technology |
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Provides research, legal representation and policy advocacy services | Commercial Services |
Decoy Therapeutics, Inc.
Decoy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale